German defense firm Renk posts record orders but faces major short bets as a key export ban threatens revenue, prompting a strategic pivot to the US.
The stock of German defense supplier Renk finds itself at the center of a significant market contradiction. On one hand, the company is posting record operational results. On the other, prominent institutional investors are building substantial short positions against the equity, betting on its decline.
Management Confidence Meets Investor Doubt
In a notable display of internal confidence, Chief Financial Officer Anja Mänz-Siebje recently purchased company shares following a price dip—a move markets typically interpret as a bullish signal from insiders. This stands in stark contrast to the actions of several major hedge funds.
AQR Capital Management has expanded its short position to 1.90%, while Marshall Wace LLP increased its bearish bet to 1.13%. A brief reduction observed in mid-February proved temporary. Only PDT Partners slightly reduced its exposure, taking its short position down to 0.79%.
The root of this institutional skepticism is clear: Germany’s suspension of defense exports to Israel directly impacts Renk. The company supplies transmission systems for Israel’s Merkava and Namer tanks, putting an estimated €80 to €100 million in revenue for 2026 at risk.
Should investors sell immediately? Or is it worth buying Renk?
In response, CEO Alexander Sagel has initiated a strategic pivot. The affected production capacity is slated for relocation to the Muskegon facility in the United States, with plans to channel future orders through the U.S. Foreign Military Sales program. The timeline and effectiveness of this transition, however, remain open questions.
Record Fundamentals Contrast with Cash Flow Concerns
Operationally, Renk’s figures are robust. The company reported record revenue of €1.37 billion for 2025. Its order backlog swelled to €6.68 billion—five times its annual revenue—while new orders reached an all-time high of €1.56 billion. Shareholders were rewarded with a 38% dividend increase.
A persistent concern lies in cash generation. Free cash flow of €67 million fell short of expectations, and the cash conversion rate dropped to 47.2%, well below the target of over 80%. This shortfall was attributed to approximately €200 million in orders being postponed, which also delayed related advance payments into the current year.
Looking ahead to 2026, management forecasts revenue exceeding €1.5 billion and an adjusted EBIT between €255 million and €285 million. Furthermore, Renk plans a major production ramp-up, aiming to increase annual transmission output from the current 200-300 units to 800 by the end of 2026.
Renk at a turning point? This analysis reveals what investors need to know now.
Key Dates and Persistent Pressure
Despite these strong fundamentals, Renk’s share price remains approximately 39% below its October peak of €88.73 and trades significantly under its 200-day moving average of €61.91. A recent weekly gain of over 15% captured attention but has not yet reversed the overarching downward trend.
Two imminent events will provide critical tests. The Q1 pre-close call on April 22nd will be followed by the quarterly results release on May 6th. These updates should reveal whether the delayed €200 million in orders have been successfully converted into revenue as planned and if the U.S. relocation strategy is effectively mitigating the Israel-related risk. Until these uncertainties are resolved, the headwinds from short-sellers are likely to persist.
Ad
Renk Stock: New Analysis – 3 April
Fresh Renk information released. What’s the impact for investors? Our latest independent report examines recent figures and market trends.